Paige Introduces Advanced Integration Capabilities to the Paige Platform, A Single Solution that Integrates the Entire Digital Pathology Ecosystem and Streamlines Workflows

Clinically Utilized by Labs Throughout the World, the Paige Platform is the Only Digital Pathology Solution Built for AI Offering Flexibility, Scalability, and Customization

NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, today introduced new advanced integration capabilities to the Paige Platform, a holistic web-based solution that enables complete digital pathology workflows and supports the evolving needs of today’s modern lab.

With Paige’s flexible platform at the nexus of the digital pathology ecosystem, labs and pathologists can connect their existing and future digital pathology applications into a single environment managed by Paige. The Platform’s flexibility is powered by a set of APIs that allow for unlimited vendor-neutral integrations​ and enable custom workflows to be built on top of Paige’s already robust native capabilities. In addition to integrating within the workflow, the solution enables seamless access to both Paige’s AI solutions and third-party AI applications. This helps to support labs in taking an iterative approach to digital pathology adoption, reducing upfront investment, avoiding vendor lock-in and making the digital transition a frictionless experience for the entire pathology department.

“Paige is the only AI-powered digital pathology platform being used daily all over the world that offers truly open, secure and scalable API capabilities. The Paige Platform drives diagnostic confidence and efficiency for pathologists in their quest to diagnose cancer quickly and accurately every single time,” said Andy Moye, Ph.D., Chief Executive Officer at Paige. “The open platform is thoughtfully designed to empower labs and pathologists to customize their workflows to their unique needs and leverage AI at all steps from case creation to reporting.”

The Paige Platform was developed for superior user experience and functionality​, placing everything a digital pathologist may need at their fingertips, including diverse WSI scanner and LIS integration capabilities, a CE-IVD & UKCA marked and FDA-cleared whole slide image viewer^*, a digital case manager to help prioritize and streamline case review and immediate access to Paige and third-party AI applications. The Paige system is supported by sophisticated, economical data management and cloud-storage options.

The Paige Platform was developed against the most secure standards in the industry, achieving ISO 27001 certification. Paige is also HIPAA and GDPR compliant.

*In the United States, European Union & United Kingdom, FullFocus® (K201005) is cleared for clinical use with various scanner brands and models, including Philips Ultrafast, Leica AT2, Hamamatsu S60 and S360, and 3DHistech P1000 scanners.

About Paige
Paige uses the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.

For additional information, please visit: https://www.paige.ai, Twitter and LinkedIn.